Autoantibodies, cutaneous subset and immunosuppressants contribute to the cancer risk in systemic sclerosis

Autoantibodies, cutaneous subset and immunosuppressants contribute to the cancer risk in systemic sclerosis

Objective Systemic sclerosis (SSc) is associated with an increased risk of cancer. We aimed to assess the prevalence of cancer in our cohort and to explore possible associations with clinical, immunological and treatment characteristics.Methods Our retrospective monocentric cohort study of patients...

Full description

Saved in:

Bibliographic Details
Main Authors:	Maria De Santis, Carlo Selmi, Angela Ceribelli, Stefanos Bonovas, Francesca Motta, Antonio Tonutti, Natasa Isailovic, Rita Ragusa, Emanuele Nappi
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-09-01
Series:	RMD Open
Online Access:	https://rmdopen.bmj.com/content/10/3/e004492.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Serum IL-23 levels reflect a myeloid inflammatory signature and predict the response to apremilast in patients with psoriatic arthritis
by: Maria De Santis, et al.
Published: (2024-12-01)

Cancer in connective tissue disease
by: Antonio Tonutti, et al.
Published: (2025-05-01)

Comparative Efficacy of Immunosuppressive Therapies in the Treatment of Diffuse Cutaneous Systemic Sclerosis
by: Barbara White, et al.
Published: (2025-03-01)

Profile of autoantibodies in systemic sclerosis
by: M. N. Starovoitova, et al.
Published: (2016-10-01)

Redefining Systemic Sclerosis Classification: Anti-Topoisomerase Antibody as a Superior Predictor of Interstitial Lung Disease and Skin Progression Compared to Limited Cutaneous Systemic Sclerosis Subset
by: Chana Chaovanitkul, et al.
Published: (2025-07-01)

Cutaneous Coinfection of Cytomegalovirus and Mycobacterium chelonae Accelerated by Immunosuppression
by: Yutaka Tsutsumi, et al.
Published: (2021-01-01)

AUTOANTIBODIES IN SYSTEMIC SCLEROSIS: SPECTRUM, CLINICAL ASSOCIATIONS, AND PROGNOSTIC VALUE
by: L. P. Ananyeva, et al.
Published: (2016-03-01)

Autoantibodies in systemic sclerosis: From disease bystanders to pathogenic players
by: Aurélien Chepy, et al.
Published: (2025-06-01)

The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.
by: Emanuele D'Amico, et al.
Published: (2016-01-01)

Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis
by: Zhong-Xiang Xie, et al.
Published: (2015-01-01)

Immunosuppression and Outcomes in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck
by: Doriana Iancu, et al.
Published: (2025-01-01)

Serum Islet Cell Autoantibodies During Interferon α Treatment in Patients With HCV-Genotype 4 Chronic Hepatitis
by: Gamal Badra, et al.
Published: (2006-01-01)

CNS and cutaneous involvement in tuberous sclerosis complex
by: Fernanda Frotte Bopp Salomon, et al.
Published: (2015-09-01)

Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome.
by: Vito Lampasona, et al.
Published: (2013-01-01)

Single-cell RNA sequencing reveals an IL1R2+Treg subset driving immunosuppressive microenvironment in HNSCC
by: Haiyan Guo, et al.
Published: (2025-03-01)

Siglec-9+ tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer
by: Yan Huang, et al.
Published: (2023-09-01)

Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis?
by: Oliver Distler, et al.
Published: (2024-07-01)

Cutaneous bacillary angiomatosis in the setting of immunosuppression: A rare case in a heart transplant recipient
by: Chloe Devoy, et al.
Published: (2025-07-01)

Differences in nailfold capillaroscopy findings between limited and diffuse cutaneous systemic sclerosis: a detailed analysis
by: Sabrina Paolino, et al.
Published: (2025-07-01)

Identification of nuclear valosin-containing-protein-like as a target of anti-nuclear autoantibodies in systemic sclerosis
by: Zitao Zeng, et al.
Published: (2025-01-01)

Cutaneous infection with Mycobacterium chelonae in a patient with multiple sclerosis
by: Morteza Masoumi, et al.
Published: (2024-01-01)

Use of fibrates and cancer risk: a systematic review and meta-analysis of 17 long-term randomized placebo-controlled trials.
by: Stefanos Bonovas, et al.
Published: (2012-01-01)

Clinical trajectories of hand function impairment in systemic sclerosis: an unmet clinical need across disease subsets
by: Lorraine Green, et al.
Published: (2024-02-01)

Obesity and fibromyalgia are associated with Difficult-to-Treat Rheumatoid Arthritis (D2T-RA) independent of age and gender
by: Nicoletta Luciano, et al.
Published: (2025-01-01)

Atypical cutaneous presentation of tuberous sclerosis complex: Giant angiofibroma on the scalp
by: Leonardo Furtado Freitas, et al.
Published: (2021-12-01)

Cutaneous presentations of systemic sclerosis in skin of colour: A systematic review
by: Alicia Podwojniak, et al.
Published: (2024-12-01)

Exploring lymphocyte subsets in COVID-19 patients: insights from a tertiary academic medical center with a high proportion of patients on immunosuppression
by: Katrijn Daenen, et al.
Published: (2024-12-01)

Blood immunophenotyping of multiple sclerosis patients at diagnosis identifies a classical monocyte subset associated to disease evolution
by: Stéphane Rodriguez, et al.
Published: (2025-01-01)

Identifying Subsets of Cancer Patients with an Increased Risk of Developing Cutaneous Melanoma: A Surveillance, Epidemiology, and End Results–Based Analysis
by: Thomas Z. Rohan, et al.
Published: (2025-01-01)

The global burden of enteric fever, 2017–2021: a systematic analysis from the global burden of disease study 2021Research in context
by: Daniele Piovani, et al.
Published: (2024-11-01)

Dynamics of interstitial lung disease following immunosuppressive treatment differ between antisynthetase syndrome and systemic sclerosis
by: Ophir Freund, et al.
Published: (2025-05-01)

Anti-hnRNP B1 (RA33) Autoantibodies Are Associated with the Clinical Phenotype in Russian Patients with Rheumatoid Arthritis and Systemic Sclerosis
by: Aleksey Maslyanskiy, et al.
Published: (2014-01-01)

On subsets of asymptotic bases
by: Xu, Ji-Zhen, et al.
Published: (2024-02-01)

Maximal Consistent Subsets
by: Robert Malouf
Published: (2021-03-01)

CLINICAL EFFECTIVENESS OF HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE SCLEROSIS PATIENTS
by: D. A. Fedorenko, et al.
Published: (2014-12-01)

Classification of Subsets of the Projective Line of Order Thirty Two and its Partitioned into Distinct Subsets
by: zainab abbas, et al.
Published: (2025-04-01)

Upadacitinib as a potential management option for diffuse cutaneous systemic sclerosis: A case report
by: Sidra Sarfaraz, et al.
Published: (2025-06-01)

Primary cutaneous marginal zone lymphoma in a patient with multiple sclerosis under fingolimod therapy
by: Thilo Gambichler, et al.
Published: (2025-07-01)

TNFAIP2 deficiency drives formation of an immunosuppressive tumor microenvironment and confers resistance to anti-PD-1 therapy in skin cutaneous melanoma
by: Yaning Wang, et al.
Published: (2025-07-01)

Peculiarities of cutaneous angiosarcoma
by: Sinval Soares Cruvinel, et al.
Published: (2020-03-01)